| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |